Voyager Therapeutics, Inc. (BMV:VYGR)

Mexico flag Mexico · Delayed Price · Currency is MXN
70.00
0.00 (0.00%)
At close: Jan 5, 2026
-57.58%
Market Cap3.59B
Revenue (ttm)574.40M
Net Income (ttm)-2.33B
Shares Outn/a
EPS (ttm)-39.79
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume41
Average Volume1,815
Open70.00
Previous Closen/a
Day's Range70.00 - 70.00
52-Week Range58.00 - 94.00
Betan/a
RSI36.77
Earnings DateMar 6, 2026

About Voyager Therapeutics

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company’s lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer’s disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treat... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 172
Stock Exchange Mexican Stock Exchange
Ticker Symbol VYGR
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements